EN
- ES
- EN
Jump Main Menu. Go directly to the main content
Agenda de actividades
Start of main content
Down Syndrome. From the molecular mechanisms to clinical trials
Life and Matter Sciences Series of Conferences February 4, 2016 Madrid
General information
Venue: Salón de Actos Fundación Ramón Areces c/ Vitruvio, 5. 28006 Madrid
Organized by:
Fundación Ramón Areces and Nature Publishing Group
- Description
- Programme
Down's Syndrome is a genetic alteration saused by an extra or partial copy of chromosome 21. It is the most frequent viable chromosomal alteration in human beings, which affects more than 30,000 people in Spain, approximately one in every 750 births. Although no cure has been developed or Down's Syndrome, recent studies are working on furthering our knowledge of the mechanisms that cause the symptoms and on identifying the genes that produce an abnormal amount of proteins. The result of these studies could provide information about the cell pathways and processes involved in this disorder and would allow us to harbour hopes of achieving future treatments that would alleviate at least some of the symptoms.
Thursday, 4
17:30
Presentation
Raimundo Pérez-Hernández y Torra
Director, Fundación Ramón Areces. Spain.
Federico Mayor Zaragoza
President, Scientific Council. Fundación Ramón Areces. Spain.
Soledad Santos Suárez
Director Editorial España y Portugal, Springer Healthcare, a Springer Nature business.
17:45
Introduction
Juan Carlos López
Former editor of Nature Medicine, New York. USA.
Conferences
18:00
Using mouse genetics to understand Down Syndrome
Victor Tybulewicz
Group Leader of the Francis Crick Institute. London. UK.
18:20
Drug discovery
Xavier Liogier d'Ardhuy
Senior Principal Scientist in CNS (Translational Medicine): Down Syndrome, Autism, Depression, AD. Roche Innovation Center Basel. Switzerland.
18:40
Clinical trials and basic mechanisms
Alberto Costa
Researcher at the Department of Pediatrics. School of Medicine. Case Western Reserve Univesity. Cleveland, Ohio. USA.
19:00
Molecular mechanisms of learning in relation to Down syndrome
Mara Dierssen
Head of Group, Cellular Neurobiology Laboratory and Systems. Center of Genomics Regulation in Barcelona. President of the Spanish Society of Neuroscience. Spain.
19:20
Discussion
Moderator:
Juan Carlos López
Round table
Victor Tybulewicz, Xavier Liogier D'ardhuy, Alberto Costa and Mara Dierssen
-
Activities related
-
Projects related
-
News related
-
Publications related
-
20
Dec
2022
Scientific Symposium VII Reunión de Diplomacia Científica, Tecnológica y de Innovación española y de la Red de Asociaciones de Científicos e Investigadores Españoles en el Exterior, RAICEX Madrid, Tuesday and Wednesday, 20 and 21 December 2022, 12:30 hours
-
16
Feb
2023
Ciclo de conferencias y debates en ciencias Cellular therapies: New oportunities offered by genetic engineering and immunotherapy Madrid, Thursday, 16 February 2023, 17:30 hours
-
13
Feb
2025
17th edition. Cycle of conferences and debates in science Digital Twins: Technological Advances and Application Opportunities Madrid, Thursday, 13 February 2025, 17:30 hours
- Dendritic alterations in Down's Syndrome: the role of the pathway regulating local mTOR translation 2006 Senior Researcher : María de la Luz Montesinos Gutiérrez Research Centre or Institution : Facultad de Medicina. Universidad de Sevilla
- Effect of the oleic acid neurotrophic factor in an animal model of Down syndrome. Implications for central nervous system development 2008 Senior Researcher : Ana Velasco Criado Research Centre or Institution : Instituto de Neurociencias de Castilla y León. Universidad de Salamanca.
- A knowledge-based pipeline to increase the diagnosis rate of Rare Diseases using deep sequencing 2016 Senior Researcher : Carmen Ayuso García Research Centre or Institution : Instituto de Investigación Sanitaria Fundación Jiménez Díaz (IIS-FJD, UAM). CIBERER. Madrid.
End of main content